-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618.P1.45 618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster I Clinically Relevant Abstract

Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Haley Newman, MD1, Shawn Lee, MD2, Petri Pölönen, PhD3*, Rawan Shraim, MSc4*, Yimei Li, PhD5,6,7*, Hongyan Liu, PhD8*, Tiffaney L. Vincent1*, Richard Aplenc, MD, PhD9,10,11, Changya Chen, PhD12*, Zhiguo Chen, MS13*, Caroline Diorio, MD1,14, Kimberly P. Dunsmore, MD15*, Sumit Gupta, MD, PhD16, Gang Wu, PhD17*, Kai Tan, PhD12,18*, Meenakshi Devidas, PhD, MBA19, Stuart S. Winter, MD20, Brent L. Wood, MD PhD21, Lena E. Winestone, MD22, Jason Xu, PhD23, Elizabeth A. Raetz, MD24, Mignon L. Loh, MD25, Stephen P. Hunger, MD1,26, Stanley B. Pounds, PhD27*, Kira O Bona, MD, MPH28, Charles G. Mullighan, MBBS, MD3, Jun J. Yang, PhD29 and David T. Teachey, MD1,23,30

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
5Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
6Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
7Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Phiadelphia, PA
8Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
9Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA
10Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
11Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
12Department of Biomedical and Health Informatics, University of Pennsylvania, Philadelphia, PA
13Biostatistics, Children's Oncology Group Data Center, Gainesville, FL
14Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
15Division of Oncology, University of Virginia Children’s Hospital, Charlottesville, VA
16Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
17Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
18Perelman School of Medicine, University of Pennsylvania, Philadephia, PA
19Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN
20Research Institute and Cancer and Blood Disorders Program, Children's Minnesota, Eagan, MN
21Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
22Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA
23Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
24Division of Pediatric Hematology and Oncology, Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, NYU Langone Health, New York, NY
25Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute and Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA
26Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
27Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
28Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
29Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
30Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Rutledge, PA

Valeriya Dimitrova1,2,3, Noori Sotudeh, PhD1,2,4*, Birgit Knoechel, MD, PhD1,2,3,5, Jens G. Lohr, MD, PhD3,6, Anna Montanaro1,7*, Sayalee V. Potdar8*, Julia Frede, PhD, MPhil2,3,6, Alexandria Van Scoyk9*, Shruti Bhatt, PhD10, Praveen Anand, PhD6*, Jon C. Aster, MD, PhD2,11, David M Weinstock12,13 and Anthony G. Letai, MD, PhD2,10

1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
2Harvard Medical School, Boston, MA
3Broad Institute of MIT and Harvard, Cambridge, MA
4Broad Institute of MIT and Harvard, Boston, MA
5Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA
6Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
7Department of Medicine and Surgery, University of Parma, Parma, Italy
8Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA
9Dana Farber Cancer Institute, Boston, MA
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Brigham and Women's Hospital, Boston, MA
12Dana-Farber Cancer Institute, Jamaica Plain, MA
13Broad Institute of Harvard and MIT, Boston, MA

Cédric G van der Ham, MSc1*, Stefan H Lelieveld, PhD1*, Željko Antic1,2*, Marley Yeong, MSc1*, Lianne C Suurenbroek, MSc1*, Dorette S van Ingen Schenau1*, Lennart A. Kester, PhD1,3*, Liset Westera, PhD1,3*, Edwin Sonneveld, PhD1,3*, Peter M. Hoogerbrugge, MD, PhD1,3, Vincent H.J. van der Velden, PhD4*, Frank N van Leeuwen, PhD1 and Roland P. Kuiper, PhD1,5

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Institute of Human Genetics, Medical School Hannover, Hannover, Germany
3Dutch Childhood Oncology Group, Utrecht, Netherlands
4Department of Immunology, Laboratory Medical Immunology, Erasmus University Medical Center, Rotterdam, Netherlands
5Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands

Britt M T Vervoort1*, Miriam Butler, PhD1*, Dorette van Ingen Schenau1*, Vincent H.J. van der Velden, PhD2*, Beat Bornhauser, PhD3*, Jean-Pierre Bourquin, MD, PhD3, Laurens T van der Meer, PhD1 and Frank N van Leeuwen, PhD1

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Erasmus Medical Center, Rotterdam, Netherlands
3University Children's Hospital Zurich, Zurich, Switzerland

Hanna Thorsson, PhD1*, Rasmus Henningsson, PhD2*, Noelia Puente-Moncada, PhD2*, Carl Sandén, PhD2*, Signe Modvig, MD, PhD3, Marianne Rissler, MSc2*, Kajsa Paulsson, PhD2, Anders Castor, MD, PhD4*, Cornelis Jan Pronk, MD, PhD4*, Hanne Vibeke Marquart, MD, PhD3*, Kjeld Schmiegelow, MD, DMSc5, Christina Orsmark-Pietras, PhD2*, Henrik Lilljebjörn, PhD2* and Thoas Fioretos, MD, PhD2

1Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden
2Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden
3Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
4Childhood Cancer Center, Skane University Hospital, Lund, Sweden
5Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

Vera H Jepsen, MSc1*, Daniel Hein, PhD1*, Daniel Picard, MSc1,2,3*, Tobias Lautwein, PhD4*, Rabea Wagener, PhD1*, Nan Qin, PhD1,2,3,5*, Annika Filip, BSc1*, Merja Heinäniemi, PhD6*, Arndt Borkhardt, MD1,3 and Ute Fischer, PhD1,3*

1Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany
2Institute of Neuropathology, Heinrich Heine University, Medical Faculty, Duesseldorf, Germany
3German cancer consortium (DKTK), partner site Essen/Duesseldorf, Duesseldorf, Germany
4Genomics Transcriptomics Laboratory, Biomedical Research Center, Heinrich Heine University, Duesseldorf, Germany
5German Cancer Research Center (DKFZ), Heidelberg, Germany
6Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland

Rabab Allawati, MPhil1,2*, Dino Mašić, PhD1*, Sarah Lawon1*, Ajay Vora, MD3 and Julie Irving, PhD4

1Birmingham Children’s Hospital, Birmingham, United Kingdom
2Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, ENG, United Kingdom
3Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
4Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

Ole Østergaard, Msc, PhD1*, Hanne Vibeke Marquart, MD, PhD2*, Maria Thastrup, PhD3, Christian Mirian, MD4*, Bodil Als-Nielsen, MD, PhD5*, Kjeld Schmiegelow, Professor M.D. DMSc.6,7*, Jesper V Olsen, Professor1* and Signe Modvig, MD, PhD2,8

1Novo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
3Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark
4Dept of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
5Dept of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, DNK
6University of Copenhagen, The Institute of Clinical Medicine, Copenhagen, Denmark
7Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
8Faculty of Medicine, Institute of Clinical Medicine, University of Copenhagen, Denmark., Copenhagen, Denmark

Jiawang Ou*, Xiuli Xu*, Zicong Huang*, Shiyu Deng*, Cai Zihong*, Bingqing Tang*, Xiaojie Liang*, Zhengwei Wu*, Yiqian Liu*, Lingling Zhou*, Qifa Liu, MD and Hongsheng Zhou*

Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Teena Bhatla, MD1, Laura Hogan, MD2, Xinxin Xu3*, Lingyun Ji4*, Andrew J. Carroll, PhD5, Nyla A. Heerema, PhD6, Mary Shago, PhD7*, Lia Gore8, James A. Whitlock, MD9, Stephen P. Hunger, MD10, Mignon L. Loh, MD11 and Patrick A. Brown, MD12

1Children's Hospital of New Jersey at Beth Israel Medical Center, Newark, NJ
2Stony Brook Children's, Stony Brook, NY
3Children's Oncology Group, Monrovia, CA
4University of Southern California, Keck School of Medicine, Los Angeles, CA
5Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
6Department of Pathology, The Ohio State University, Columbus, OH
7Cytogenetics Laboratory, The Hospital for Sick Children, Toronto, ON, Canada
8Children's Hospital Colorado, University of Colorado, Aurora, CO
9Division of Haematology/Oncology, The Hospital For Sick Children, Toronto, ON, Canada
10Children's Hospital of Philadelphia, Philadelphia, PA
11Division of Hematology, Oncology, BMT, and Cellular Therapies, Seattle Children's Hospital, Seattle, WA
12Bristol Myers Squibb, Princeton, NJ

Jung-Hyun Kim, PhD1, Liping Li, MD, PhD1*, Zixin Zhang2*, Katharina Hayer3*, Li Luo, PhD1*, Leslie Cope, PhD4*, Lingling Xian, MD, PhD1*, Andrei Thomas-Tikhonenko, PhD5 and Linda Resar, MD1,4,6,7

1Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
2Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public health, Baltimore, MD
3Children's Hospital of Philadelphia, Philadelphia, PA
4Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
5Division of Experimental Pathology, Cancer Pathobiology, Children's Hospital of Philadelphia & University of Pennsylvania, Philadelphia, PA
6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD
7Cellular and Molecular Medicine Graduate Program, Johns Hopkins University School of Medicine, Baltimore, MD

Sarah Aminov, MSc1*, Orsi Giricz, PhD2*, R. Alejandro Sica, MD3, Veronika Polishchuk, MD4*, Bonnie Yates, NP5*, Hao-Wei Wang, MD, PhD6, Yanhua Wang, MD, PhD7*, Srabani Sahu, MSc1*, Shanisha Gordon, MSc1*, Carolina Schinke8, Kith Pradhan, PhD9*, Srinivas Aluri, PhD1*, Murali Janakiram, MD, MS10, Stefan K. Barta, MD11, Beamon Agarwal, MD, PhD12*, Mendel Goldfinger, MD13, Aditi Shastri, MD14, William Matsui, MD15, Ulrich Steidl, MD, PhD9*, Joshua Brody, MD16, Nirali N. Shah, MD17, Samir Parekh, MD18 and Amit Verma, MD, MBBS19*

1Blood Cancer Institute, Albert Einstein College of Medicine, Bronx, NY
2Leukemia and Lymphoma Society, Rye Brook, NY
3Montefiore Medical Center, New York City, NY
4Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
5Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
7Department of Pathology, Albert Einstein College of Medicine, Bronx, NY
8Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
9Albert Einstein College of Medicine, Bronx, NY
10Division of Myeloma, Department of Hematology, City of Hope National Medical Center, Duarte, CA
11Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
12Department of Hematopathology, Montefiore Medical Center, New York, NY
13Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
14Oncology, Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
15MD Health Discovery, University of Texas, Austin, TX
16Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY
17Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
18Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
19Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Anna Østergaard1,2*, Amir Enshaei, PhD3*, Rob Pieters, Prof. MD. PhD4, Ajay Vora, MD5, Martin A. Horstmann, MD6, Gabriele Escherich, MD7*, Bertil Johansson8,9, Mats Heyman10, Kjeld Schmiegelow, MD, DMSc11, Peter M. Hoogerbrugge, MD, PhD4, Monique L. den Boer, PhD4,12, Roland P. Kuiper, PhD4,13, Anthony V. Moorman14, Judith M. Boer, PhD4,12 and Frank N van Leeuwen, PhD4

1Oncode institute, Utrecht, Netherlands
2Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands
3Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, United Kingdom
4Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
5Department of Haematology, The Children's Hospital, London, United Kingdom
6University Medical Center Hamburg-Eppendorf, Hamburg, Germany
7Clinic of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Eppendorf, Germany
8Lund University Hospital, Lund, Sweden
9Department of Clinical Genetics, Pathology, and Molecular Diagnostics, Office for Medical Services, Region Skåne, Lund, Sweden
10Karolinska University Hospital, Stockholm, Sweden
11Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
12Oncode Institute, Utrecht, Netherlands
13Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands
14Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom

V. S. S. Abhinav Ayyadevara, PhD, MS1*, Gerald Wertheim, MD, PhD2,3, John Chukinas, BA4*, Joseph Patrick Loftus, BS5*, Sung June Lee, BA6*, Anil Kumar, PhD7*, Rahul S. Bhansali, MD8, Srividya Swaminathan, PhD7, Thierry Besson, PhD9*, Junwei Shi, PhD10*, John D. Crispino, PhD11, Sarah K Tasian, MD12, Martin P. Carroll, MD13 and Christian Hurtz, PhD14

1Fels Cancer Institute for Personalized Medicine, Temple University, Philadelphia, PA
2Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA
3Division of Hematology/Oncology, Department of Medicine, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA
4Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
5Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
6Systems Biology, City of Hope, Monrovia, CA
7Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA
8Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
9Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, 76000, Rouen, France
10Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
11Experimental Hematology, St. Jude Children's Research Hospital, Memphis
12Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
13Medicine, University of Pennsylvania, Philadelphia, PA
14Lewis Katz School of Medicine, Temple University, Philadelphia, PA

Laura Rachele Bettini, MD1*, Grazia Fazio, PhD2*, Claudia Saitta, PhD3*, Sonia Palamini, Graduated student3*, Chiara Buracchi, PhD, MSc4*, Stefano Rebellato, Graduated student3*, Nicola Santoro, MD5*, Cristiano Simone, MD6,7*, Andrea Biondi, MD3 and Giovanni Cazzaniga, PhD8,9*

1Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, AL, Italy
2Tettamanti Research Center, Dept. Pediatrics, Clinica Pediatrica Univ. Milano Bicocca Ospedale San Gerardo, Monza, MB, Italy
3Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
4Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
5Department of Pediatrics, Policlinico di Bari, Bari, Italy
6Medical Genetics, National Institute for Gastroenterology, IRCCS ‘S. de Bellis’ Research Hospital, Castellana Grotte, Italy
7Medical Genetics, Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari Aldo Moro, Bari, Italy
8Tettamanti Research Center, Pediatrics, University of Milan Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, MZ, Italy
9Medical Genetics, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

Catherine D Falkenstein, BS1*, Lisa M Niswander, MD, PhD2, Linda Kessler, BA3*, Blake Tomkinson, PhD MBA3*, Francis Burrows, PhD3* and Sarah K Tasian, MD2,4

1Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA
2Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
3Kura Oncology, San Diego, CA
4Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA

*signifies non-member of ASH